Pacira BioSciences' Other Non Operating Income fell 70573.77% to -$983000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.3 million, marking a year-over-year decrease of 20116.07%. This contributed to the annual value of $7.5 million for FY2024, which is 14441.69% up from last year.
Per Pacira BioSciences' latest filing, its Other Non Operating Income stood at -$983000.0 for Q3 2025, which was down 70573.77% from -$10.7 million recorded in Q2 2025.
Pacira BioSciences' Other Non Operating Income's 5-year high stood at $7.5 million during Q2 2024, with a 5-year trough of -$16.9 million in Q1 2023.
Its 5-year average for Other Non Operating Income is -$1.9 million, with a median of -$159000.0 in 2024.
Its Other Non Operating Income has fluctuated over the past 5 years, first plummeted by 2293913.04% in 2022, then skyrocketed by 289479.55% in 2024.
Pacira BioSciences' Other Non Operating Income (Quarter) stood at -$66000.0 in 2021, then soared by 222.73% to $81000.0 in 2022, then crashed by 620.99% to -$422000.0 in 2023, then soared by 71.09% to -$122000.0 in 2024, then tumbled by 705.74% to -$983000.0 in 2025.
Its Other Non Operating Income stands at -$983000.0 for Q3 2025, versus -$10.7 million for Q2 2025 and $4.4 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value